Colombia — Pharmaceuticals (6 Listings)

Six companies in this directory are classified under pharmaceuticals. Six is a small sample for a country-wide sector, not enough to treat as a representative map of Colombia's pharmaceutical manufacturing base — only as a short list of starting points for outreach.

The regulatory problem is bigger than the manufacturing problem

For a US buyer, the hard part of sourcing pharmaceuticals from Colombia is rarely finding a facility that can physically make the product. It is clearing the regulatory path that lets that product legally enter the United States. Any facility that manufactures, repacks, relabels or salvages a drug product for the US market must register as a foreign drug establishment with the FDA under 21 CFR Part 207 before the drug is imported or offered for import, and must designate a US agent as part of that registration. The FDA inspects foreign drug facilities under the same statutory authority it uses domestically, and can refuse entry of a facility's drugs at the border if it refuses or delays an inspection. None of this is Colombia-specific — it is the standard the FDA applies to any foreign drug manufacturer, regardless of what the home-country regulator has already approved.

What INVIMA is, and what it is not

Colombia's national drug and food regulator is INVIMA. It is one of the small number of national authorities in the Americas that PAHO and WHO recognize as a "regional reference authority," a designation tied to a documented level of regulatory maturity that other countries in the region can lean on — a real credential worth something when judging whether Colombia's oversight is basically serious. But it carries no legal standing under the Federal Food, Drug and Cosmetic Act, and does not substitute for FDA registration. A facility can be fully INVIMA-approved and still need FDA establishment registration, inspection, and — depending on the product — its own approval pathway before it ships to a US customer.

Where the more realistic near-term opportunity sits

Contract manufacturing of a regulated drug product in Colombia for the US market is a heavyweight undertaking: FDA registration, inspection readiness, technology transfer, and often a full approval process, all ahead of volume production — a multi-year project for most small and mid-size buyers, not a quarter's sourcing decision. Categories adjacent to pharmaceuticals — cosmetics, dietary supplements, personal care, non-sterile medical consumables — generally carry a lighter US compliance burden. Cosmetics need FDA facility registration and product listing under the Modernization of Cosmetics Regulation Act, but not premarket approval; supplements and many consumables follow their own frameworks, distinct from drug approval. The categories genuinely differ in weight, but "lighter" is relative — confirm the specific pathway for your product before assuming it is simple.

What to ask suppliers in this category

• Is the facility currently registered with the FDA as a foreign drug establishment?
• Has it been inspected by the FDA, and can it share the outcome or any observations and its response?
• What is its experience transferring a process from an existing US or third-country manufacturer?
• Can it produce stability data appropriate to the product and intended US shelf-life claims?
• What are its minimum batch sizes, and do they fit a launch-scale order?

What this directory does and doesn't tell you

The six listings here give a name, sector and location — nothing on regulatory status, certifications, export history or capacity. Given how much of the real work in this category is regulatory rather than physical, that gap matters more here than in most sectors. Treat this list as a starting point for outreach, and get a direct answer on FDA registration status before any other due diligence step.

Pharmaceuticals records in Colombia (6)

Compiled from public sources. A listing is a starting point for research, not an endorsement or a capability claim.

← All Colombia records